If you are over age 75, and taking an anticoagulant, the old standard may be the gold standard, Mayo Clinic researchers and collaborators have determined.
May 29, 2015
0
29
In a clinical practice guideline issued jointly by the American College of Gastroenterology and the Canadian Association of Gastroenterology and published online March 17 in the American Journal of Gastroenterology, updated ...
Mar 28, 2022
0
3
A novel blood thinner recently approved by the FDA, dabigatran (Pradaxa), has been rapidly adopted into clinical practice, yet thus far has had little impact on improving treatment rates for atrial fibrillation. This is according ...
Sep 21, 2012
0
0
Many patients who have experienced strokes or mini strokes take blood thinners such as aspirin or warfarin (Coumadin) to reduce the risk of blood clots that can cause strokes.
May 29, 2013
0
0
(HealthDay)—Obese patients taking the blood thinner warfarin appear to have almost twice the risk of severe stomach bleeding compared to their normal-weight counterparts, a new study suggests.
May 9, 2015
0
66
Although current guidelines recommend 3 months of anticoagulation treatment after bioprosthetic aortic valve replacement surgery, a study that included more than 4,000 patients found that patients who had warfarin therapy ...
Nov 27, 2012
0
0
(HealthDay)—For patients with atrial fibrillation hospitalized with stroke or transient ischemic attack, use of novel oral anticoagulants (NOACs) has increased over time, according to a study published online June 9 in ...
Jun 15, 2015
0
11
A review of clinical trials comparing warfarin with other medications for stroke prevention suggests that warfarin was associated with a low risk of stroke or non-central nervous system embolism in patients with nonvalvular ...
Mar 26, 2012
0
0
(HealthDay)—For patients with atrial fibrillation, decline in renal function is significantly greater with warfarin versus dabigatran etexilate (DE), according to a study published in the June 16 issue of the Journal of ...
Jun 10, 2015
0
9
The clot-busting medicine, tPA (tissue plasminogen activator), is safe to use in acute stroke patients already on the home blood thinner warfarin, according to researchers from Duke Clinical Research Institute (DCRI). This ...
Jun 26, 2012
0
0
